# VA Conditioning Regimen Allo-HSCT for Elderly Higher-risk MDS

> **NCT06471946** · PHASE1,PHASE2 · RECRUITING · sponsor: **Navy General Hospital, Beijing** · enrollment: 54 (estimated)

## Conditions studied

- Higher-risk Myelodysplastic Syndromes

## Interventions

- **DRUG:** Venetoclax Plus Azacytidine Conditioning Regimen Allo-HSCT

## Key facts

- **NCT ID:** NCT06471946
- **Lead sponsor:** Navy General Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-01
- **Primary completion:** 2029-09-01
- **Final completion:** 2030-09-01
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2024-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06471946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06471946, "VA Conditioning Regimen Allo-HSCT for Elderly Higher-risk MDS". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT06471946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*